InterCure Ltd.
INCR
$1.60
$0.053.23%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -16.11% | -2.39% | 17.86% | 38.55% | 69.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -16.11% | -2.39% | 17.86% | 38.55% | 69.40% |
| Cost of Revenue | 4.39% | 16.20% | 35.76% | 50.29% | 77.06% |
| Gross Profit | -41.89% | -24.47% | -2.71% | 25.00% | 60.67% |
| SG&A Expenses | -11.12% | -2.00% | 26.25% | 51.11% | 70.46% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -62.57% | 928.94% | 101.63% | 121.34% | 89.90% |
| Total Operating Expenses | -5.64% | 21.88% | 36.45% | 54.53% | 75.21% |
| Operating Income | -101.87% | -111.63% | -74.81% | -42.94% | 33.27% |
| Income Before Tax | -220.53% | -161.91% | -88.25% | -22.30% | 132.97% |
| Income Tax Expenses | 137.55% | -165.05% | -162.03% | -116.59% | -92.98% |
| Earnings from Continuing Operations | -227.34% | -160.14% | -40.67% | 53.17% | 499.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 61.76% | 294.36% | 193.57% | 169.94% | 133.06% |
| Net Income | -221.63% | -150.96% | -18.90% | 102.74% | 863.13% |
| EBIT | -101.87% | -111.63% | -74.81% | -42.94% | 33.27% |
| EBITDA | -82.68% | -100.14% | -64.02% | -34.70% | 34.62% |
| EPS Basic | -213.40% | -150.95% | -24.69% | 88.54% | 799.45% |
| Normalized Basic EPS | -143.70% | -132.58% | -101.36% | -48.16% | 58.54% |
| EPS Diluted | -216.74% | -153.69% | -19.14% | 114.95% | 1,236.86% |
| Normalized Diluted EPS | -145.63% | -133.42% | -101.27% | -46.16% | 64.64% |
| Average Basic Shares Outstanding | 6.83% | 22.05% | 25.99% | 22.80% | 29.54% |
| Average Diluted Shares Outstanding | 4.69% | 19.59% | 23.36% | 16.38% | 23.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |